Last reviewed · How we verify
Partial seizures
Approved treatments
- Neurontin · Pfizer Inc.
Gabapentin binds with high-affinity to α2δ subunit of voltage-activated calcium channels; precise mechanism unknown.
Clinical guidelines
- FDA label — adj
Gabapentin Capsules, USP are indicated as adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Partial seizures patent landscape — cliff calendar, originator estates, attackable patents
- Partial seizures treatment landscape brief
- Partial seizures treatment updates RSS
Frequently asked questions about Partial seizures
What drugs treat Partial seizures?
Tracked treatments include Neurontin.
What is the treatment for Partial seizures?
Standard treatment for Partial seizures includes Neurontin. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Partial seizures?
FDA label publishes guidelines for Partial seizures. 1 guideline references tracked.
Related
- Treatment landscape: Partial seizures patent cliff · Partial seizures CI report
- Treatment: Neurontin · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing